therapeutics
Last edited 10/2018 and last reviewed 02/2023
ACE inhibitors in heart failure
alcohol and coronary heart disease
alpha blockers in hypertension
angioplasty and atherosclerotic renal artery stenosis
anti-hypertensive therapy and risk of type II diabetes
aspirin in atrial fibrillation
beta blockers in cardiac failure
beta blockers in myocardial infarction
bypass grafting versus medical treatment in angina
CABG vs. angioplasty - trial evidence
calcium channel blockers in myocardial infarction
digoxin in heart failure - trial evidence
Heart Outcomes Prevention Evaluation Study
Heart Outcomes Prevention Evaluation study in diabetics
IONA study (Impact Of Nicorandil in Angina)
Hypertension Optimal Treatment study
N-BNP levels to guide heart failure treatment
PARADIGM - HF sacubutril versus enalapril in heart failure
prevention of thromboembolism in atrial fibrillation
primary prevention of stroke in atrial fibrillation
secondary prevention of stroke in atrial fibrillation
therapeutic trials in congestive heart failure
treating hypertension to prevent stroke
trials of therapeutic intervention in MI
trials related to ACE inhibitors in cardiac failure
trials with respect to treatment of hypercholesterolaemia
Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Study
Valsartan Anti-hypertensive Long-term Use Evaluation (VALUE)
prasugrel or ticagrelor in ACS (acute coronary syndrome) - comparative evidence
bedtime versus morning ingestion of hypertension and cardiovascular (CV) risk